Venus Concept Inc

VERO18 Jan 2025
Healthcare
$0.35
-0.07 (-7.03%)
Lowest Today
$0.34
Highest Today
$0.36
Today’s Open
$0.35
Prev. Close
$0.37
52 Week High
$2.22
52 Week Low
$0.28
To Invest in Venus Concept Inc

Venus Concept Inc

Healthcare
VERO18 Jan 2025
-0.07 (-7.03%)
1M
3M
6M
1Y
5Y
Low
$0.34
Day’s Range
High
$0.36
0.34
52 Week Low
$0.28
52-Week Range
52 Week High
$2.22
0.28
1 Day
-
1 Week
-10.23%
1 month return
+12.53%
3 month return
-23.92%
6 month return
-37.47%
1 Year return
-70.57%
3 Years return
-98.63%
5 Years return
-99.59%
10 Years return
-
Institutional Holdings
Essex Woodlands Health Ventures
15.01
Masters Capital Management LLC
8.57
Vanguard Group Inc
0.45
Vanguard Institutional Extnd Mkt Idx Tr
0.45
Geode Capital Management, LLC
0.4
Fidelity Extended Market Index
0.32
HRT FINANCIAL LLC
0.25

Market Status

Fundamentals
Market Cap
2.51 mln
PB Ratio
0.25
PE Ratio
0
Enterprise Value
36.37 mln
Total Assets
93.65 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Organisation
Venus Concept Inc
Employees
304
Industry
Medical Devices
CEO
Mr. Rajiv Kanishka Liyanaarchchie De Silva
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities